Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02343536
Title A Phase 1, Open-label,Trial of Oral Azacitidine (CC-486) Plus R-CHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene Corporation
Indications

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Cyclophosphamide + Prednisone + Rituximab + Vincristine Sulfate

Azacitidine

Age Groups: adult
Covered Countries USA


No variant requirements are available.